For those looking to build a portfolio of income-producing assets that may allow one to live off of dividends in retirement (without having to sell much, if all, of one's invested shares), the following three Fidelity ETFs may be worth considering.

LOS ANGELES--(BUSINESS WIRE)--ESTC Investors Have Opportunity to Lead Elastic N.V. Securities Fraud Lawsuit with the Schall Law Firm.

Tuesday, Gilead Sciences Inc GILD reported fourth-quarter 2024 adjusted EPS of $1.90, beating the consensus of $1.70.

Amgen, Inc. (NASDAQ:AMGN ) Oppenheimer 35th Annual Healthcare Life Sciences Conference Call February 12, 2025 11:20 AM ET Company Participants Narimon Honarpour - Senior Vice President, Global Development Justin Claeys - Head of Investor Relations Casey Capparelli - Investor Relations Conference Call Participants Jay Olson - Oppenheimer & Co. Jay Olson Hello, everyone. I'm Jay Olson, one of the biotech analysts at Oppenheimer, and it's a pleasure to welcome you to Oppenheimer's 35th Annual Healthcare Conference.

iShares Morningstar Mid-Cap ETF holds 435 mid-cap stocks listed in the U.S., without factor-based selection. The underlying index is different from the S&P 400 benchmark, resulting in a better balance across sectors. The IMCB ETF has slightly outperformed other market cap-weighted ETFs in the mid-cap universe since 2011.

LOS ANGELES--(BUSINESS WIRE)--NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm.

Meta's open-source approach to AI, evidenced by projects like Llama, presents enormous opportunities for the company. Strong financials from social media advertising, with $48.39 billion in Q4 2024 revenue, support Meta's ambitious AI initiatives. The open-source strategy, validated by DeepSeek, accelerates innovation and positions Meta to stay at the cutting edge of AI development.

BlackBerry Limited (NYSE:BB ) Wolfe Research Auto, Auto Tech and Semiconductor Conference Call February 12, 2025 12:00 PM ET Company Participants John Wall - COO, QNX & Head, Product Engineering Tim Foote - CFO Conference Call Participants Shreyas Patil - Wolfe Research Shreyas Patil [Call Starts Abruptly] third parties may create. And in many ways, QNX has become the go-to OS provider for automakers.

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against FTAI Aviation Ltd. (NASDAQ:FTAI) and certain of its senior executives for potential violations of the federal securities laws.

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into TransMedics Group, Inc. (NASDAQ:TMDX) for potential violations of the federal securities laws. If you invested in TransMedics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/transmedics-group-inc.

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Crocs, Inc. (NASDAQ:CROX) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Crocs, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/crocs-inc.

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against ICON plc (NASDAQ:ICLR) and certain of its senior executives for potential violations of the federal securities laws. If you invested in ICON, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/icon-plc.

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.

NEW YORK, NY / ACCESSWIRE / February 12, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Nextracker Inc. (NASDAQ:NXT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Nextracker, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/nextracker-inc.

In an earnings season where investors are expecting nothing less of perfection, Super Micro Computer's post-earnings rally on a modest quarter accompanied by a slashed FY25 guidance is a real head-scratcher. Despite optimism on management's FY26 revenue guidance of $40 billion, it's important to remember there's currently limited reliability to the preliminary figures disclosed by management in the quarterly update. A deeper dive into management's commentary also shows signs of potential differences in their views of whether SMCI can meet its outstanding filing requirements by Nasdaq's February 25 deadline.

The CPI rose 0.5% in January, spiking Treasury yields and causing stocks to drop, signaling potential economic overheating. Inflation-indexed Treasury bonds offer inflation protection, but are subject to risks due to the US government's growing fiscal pressures and potential debt monetization. The spread between gold and real interest rates may signal the bond market is pricing in effective credit risk.

Anavex Life Sciences Corp. expects feedback from the European Medicines Agency on blarcamesine for the treatment of patients with Alzheimer's Disease by year-end of 2025. The global market for Alzheimer's Disease is estimated to reach $15.5 billion by 2031. AVXL has top-line data from the ongoing phase 2 study, using blarcamesine for the treatment of patients with Schizophrenia, expected to be released in 2025.

NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Semtech Corp. (NASDAQ: SMTC) for potential violations of the federal securities laws. If you invested in Semtech , you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/semtech-corp.

JPMorgan Chase has several rounds of layoffs coming this year, and some workers at the company have apparently started being told they will lose their jobs, according to Barron's.

NEW YORK , Feb. 12, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of TransMedics Group, Inc. (NASDAQ: TMDX) resulting from allegations that TransMedics may have issued materially misleading business information to the investing public. So What: If you purchased TransMedics securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.